Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis
GreeceStudy on Switching to Doravirine and Islatravir for People with HIV-1 on Antiretroviral Therapy
FranceStudy on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination
FranceStudy on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1
FranceStudy on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination
FinlandStudy on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
The NetherlandsStudy on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy
IcelandStudy on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement
CzechiaStudy on Pioglitazone for Adults with Non-Segmental Vitiligo
ItalyStudy on Oral and Enema Fecal Microbiota Transplantation for Children with Ulcerative Colitis
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
